Collaboration focuses on developing a KRAS G12D inhibitor, complementing Bayer’s precision oncology development portfolio in the areas of pancreatic, colorectal and lung cancer / KRAS mutations occur in nearly 25 percent of human cancers, with the…

Guest professor at the Cognitive Computational Neuroscience Lab, Freie Universität Berlin, uses language models similar to those behind ChatGPT

Neuroblastoma, a cancer mainly affecting children, is often difficult to treat. Researchers at Charité – Universitätsmedizin Berlin and the Max Delbrück Center now report a potential reason treatment sometimes fails. In the journal Cancer Discovery,*…

An interdisciplinary team of scientists from the Berlin Institute of Health at Charité (BIH), the Max Delbrück Center, the German Cancer Research Center (DKFZ), the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) and…

Beyond the hype: We are looking for AI and quantum technologies with real added value

Apply by 17 August 2025!

The EU-Japan Centre is targeting cutting-edge technologies sectors for its very first Innovation mission to Japan.

Deadline: 24.08.2025

Digital assistance system relieves nursing staff by providing real-time notifications of incontinence and movement, among other things

Eckert & Ziegler (ISIN DE0005659700) has entered a Master Service Agreement with Archeus Technologies (Archeus), a company developing multiple differentiated radiopharmaceutical therapies, for contract manufacturing of its novel investigational…

Hospitals generate vast amounts of data every day, which have the potential to significantly improve patient care. dotbase medical GmbH, a spin-off of the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin, has…